18th Sep 2020 13:48
Ap19
FORM 8.3 - Amendment to Purchase
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Barclays PLC. | |
| Company dealt in | WILLIS TOWERS WATSON PLC | |
| Class of relevant security to which the | ORD | |
| dealings being disclosed relate (Note 2) | ||
| Date of dealing | 16 September 2020 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD | ||||
| Long | Short | ||||
| Number | (%) | Number | (%) | ||
(1) | Relevant securities | ||||
2,216,016 | 1.72% | 468,877 | 0.36% | ||
|
|
|
| ||
(2) | Derivatives (other than options): |
|
|
|
|
355,000 | 0.28% | 388,524 | 0.30% | ||
|
|
|
| ||
(3) | Options and agreements to |
|
|
|
|
| purchase/sell: | 0 | 0.00% | 0 | 0.00% | |
|
|
|
| ||
| TOTAL: |
|
|
|
| |
2,571,016 | 2.00% | 857,401 | 0.67% | ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
| ||||||
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
| Purchase/sale | Number of relevant securities | Price per unit |
| Purchase | 7 | 208.6900 USD |
| Purchase | 90 | 208.5844 USD |
| Purchase | 95 | 208.5500 USD |
| Purchase | 100 | 206.6800 USD |
| Purchase | 100 | 208.6300 USD |
| Purchase | 100 | 208.0000 USD |
| Purchase | 100 | 207.9600 USD |
| Purchase | 104 | 208.6130 USD |
| Purchase | 117 | 207.5400 USD |
| Purchase | 147 | 208.4235 USD |
| Purchase | 198 | 206.9050 USD |
| Purchase | 203 | 208.5330 USD |
| Purchase | 350 | 208.2212 USD |
| Purchase | 580 | 207.4207 USD |
| Purchase | 668 | 207.1497 USD |
| Purchase | 700 | 206.9207 USD |
| Purchase | 700 | 208.4585 USD |
| Purchase | 905 | 207.6151 USD |
| Purchase | 1,153 | 208.0963 USD |
| Purchase | 1,240 | 207.9129 USD |
| Purchase | 1,300 | 208.2211 USD |
| Purchase | 1,520 | 208.5748 USD |
| Purchase | 1,838 | 208.4284 USD |
| Purchase | 2,118 | 207.9947 USD |
| Purchase | 4,373 | 207.8603 USD |
| Purchase | 7,306 | 206.9400 USD |
| Purchase | 7,652 | 208.4329 USD |
| Purchase | 8,094 | 207.2662 USD |
| Purchase | 10,898 | 206.9457 USD |
| Purchase | 11,232 | 207.7187 USD |
| Purchase | 11,326 | 208.2489 USD |
| Purchase | 13,285 | 208.0391 USD |
| Purchase | 50,420 | 208.5941 USD |
| Sale | 26 | 208.1500 USD |
| Sale | 33 | 207.2109 USD |
| Sale | 100 | 208.0700 USD |
| Sale | 117 | 207.5400 USD |
| Sale | 500 | 208.1920 USD |
| Sale | 516 | 208.6138 USD |
| Sale | 684 | 207.8693 USD |
| Sale | 864 | 208.3802 USD |
| Sale | 974 | 208.4711 USD |
| Sale | 1,714 | 208.3937 USD |
| Sale | 1,799 | 208.6105 USD |
| Sale | 2,200 | 208.6122 USD |
| Sale | 2,373 | 208.5654 USD |
| Sale | 2,963 | 208.6235 USD |
| Sale | 3,318 | 208.6561 USD |
| Sale | 3,588 | 208.5833 USD |
| Sale | 3,618 | 207.7982 USD |
| Sale | 3,700 | 208.6009 USD |
| Sale | 4,025 | 208.6484 USD |
| Sale | 6,387 | 206.9652 USD |
| Sale | 6,575 | 208.3588 USD |
| Sale | 7,352 | 208.4448 USD |
| Sale | 7,815 | 206.9400 USD |
| Sale | 10,872 | 206.9428 USD |
| Sale | 13,768 | 208.0665 USD |
| Sale | 22,562 | 207.7433 USD |
| Sale | 25,938 | 208.5743 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
| Is a Supplemental Form 8 (Open Positions) attached? | NO |
| Date of disclosure: | 18 Sep 2020 |
| Contact name: | Large Holdings Regulatory Operations |
| Telephone number: | 020 3134 7213 |
| If a connected EFM, name of offeree/offeror with which connected |
|
| If a connected EFM, state nature of connection |
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20200918005303/en/
Copyright Business Wire 2020
Related Shares:
Barclays